Drug Type Small molecule drug |
Synonyms Dual Aβ/ tau oligomer inhibitor (Treventis), TRV 101, TRV101 |
Target |
Action inhibitors |
Mechanism APP inhibitors(Beta amyloid A4 protein inhibitors), TAU inhibitors(Microtubule-associated protein tau inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Preclinical | Canada | 05 Dec 2023 | |
Neurodegenerative Diseases | Preclinical | France | 04 Jan 2018 | |
Neurodegenerative Diseases | Preclinical | France | 04 Jan 2018 |